Bojungikki-tang improves response to pd-l1 immunotherapy by regulating the tumor microenvironment in mc38 tumor-bearing mice

HIGHLIGHTS

• who: Bojungikki-Tang Improves Response and collaborators from the Institute of Oriental Medicine, Daejeon, South Korea, College of Pharmacy, Chungnam National University, Daejeon, South Medicine, China have published the paper: Bojungikki-Tang Improves Response to PD-L1 Immunotherapy by Regulating the Tumor Microenvironment in MC38 Tumor-Bearing Mice, in the Journal: (JOURNAL)
• what: The study provides a rationale for combinatorial treatment using ICIs and herbal medicines. The authors have not yet investigated the detailed signaling pathways on MDSCs-mediated immune suppression by BJIKT, further studies will be continued to clarify the relationship between splenic MDSCs . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.